it is the most common soft tissue sarcoma occurring in children erms is also known as fusion negative rhabdomyosarcoma fn rms as tumors of this subtype are unified by their lack of a pax3 foxo1 fusion oncogene or other pax fusions seen in alveolar rhabdomyosarcoma erms or fn rms is the more common of two major sub types of rhabdomyosarcoma the other being alveolar rhabdomyosarcoma arms also known as fusion positive rms fp rms commonly fn rms is driven by a mutation in the ras family of proto oncogenes creating a powerful signal which is now known to promoter tumor growth by preventing muscle lineage progression by blocking expression of the transcription factor myog inhibition of this signaling pathway with trametinib has been recently shown to overcome this differentiation block and reduce tumor progression in animal models of fn rms fn rms has been informally classified as a small round blue cell tumor because of the characteristic microscopic appearance of its cells after histological staining with hematoxylin and eosin the prognosis for rhabdomyosarcoma has improved greatly in recent decades with over 70 of patients surviving for five years after diagnosis nevertheless some fn rms patients with a rare leu122arg mutation